UK regulator opens inquiry into Unilever and McCormick’s $65bn food deal

Unilever PLC (LSE: ULVR) and McCormick & Company Incorporated (NYSE: MKC) have entered a new regulatory phase in their proposed $65 billion food combination after Britain’s Competition and Markets Authority formally launched a merger investigation on September 16. The regulator is assessing whether the transaction could materially reduce competition in the United Kingdom, with a Phase 1 decision due by November 11. The development shifts attention from the strategic logic of Unilever’s food separation toward the practical question of whether the combination can clear competition reviews without remedies that alter its economics.

The transaction would bring brands including Knorr and Hellmann’s together with McCormick businesses such as French’s and Frank’s RedHot, creating one of the world’s largest companies focused on flavorings and packaged food products. Under the announced structure, Unilever and its shareholders would own 65% of the fully diluted combined company, including a 9.9% interest retained directly by Unilever, while existing McCormick shareholders would hold the remaining 35%.

Why is the UK review important for Unilever’s portfolio transformation?

The transaction is central to Chief Executive Fernando Fernandez’s effort to reshape Unilever around businesses where management sees stronger growth and greater strategic coherence. When the transaction was announced in March, it valued Unilever’s food assets at close to $45 billion and was structured to provide Unilever with substantial cash proceeds while shifting the food portfolio into a separately controlled combination with McCormick.

That makes regulatory execution important beyond the food division itself. Unilever has been progressively simplifying its portfolio, including separating ice cream and redirecting attention toward beauty, wellbeing, personal care and home-care categories. Successfully completing the McCormick transaction would move another mature business away from the centre of the group while preserving economic participation through the equity structure.

The rationale is partly about growth rates and partly about management focus. Large consumer-products conglomerates have historically argued that scale provides procurement and distribution advantages, but investors increasingly scrutinise whether sprawling portfolios dilute capital allocation and managerial attention. Unilever’s strategy effectively tests whether shareholders receive more value from a focused consumer group plus ownership in a dedicated food company than from keeping those activities integrated.

What competition questions could the CMA examine?

The Competition and Markets Authority has not concluded that the transaction harms competition. Its September 16 action formally begins the Phase 1 process, during which the regulator will examine whether the anticipated acquisition creates a realistic prospect of a substantial lessening of competition in relevant UK markets. The regulator had already opened an information-gathering process in July and invited interested parties to submit initial comments before moving to the formal investigation.

The combined portfolio would span cooking aids, sauces, seasonings, condiments and other flavor-related categories sold through many of the same supermarkets and food-service channels. Regulators may therefore examine individual product categories rather than treating the transaction as a single global packaged-food market. Brand concentration, retailer bargaining power and the availability of private-label or branded alternatives could all become important.

The November 11 deadline gives investors a defined first checkpoint. A Phase 1 clearance would reduce one element of execution risk, while identified competition concerns could lead to undertakings, asset disposals or a deeper Phase 2 review. The consequences would depend heavily on which product markets the regulator considers potentially concentrated.

Why does McCormick want greater scale in packaged food?

McCormick is already a global leader in spices, seasonings and flavor solutions, but the Unilever transaction would materially expand its reach into established food brands and additional geographic markets. The combination comes as packaged-food companies confront higher input costs, cautious consumers and growing pressure from supermarket private labels. Scale can strengthen purchasing power, distribution efficiency and marketing resources, although larger portfolios also create integration complexity.

For McCormick, the transaction is consequently transformative in a way that is less dramatic for Unilever. Unilever is divesting and refocusing, while McCormick is effectively stepping into a much larger operating footprint. That asymmetry is important when assessing integration risk because McCormick must absorb businesses of considerable scale while protecting the brand strength and margins that justify the transaction.

Cost synergies are usually an important part of transactions of this magnitude, but the strategic value will ultimately depend on whether the combined company can generate stronger organic growth rather than merely reduce overlapping expenses. Packaged food remains intensely competitive, and gaining brands does not automatically create pricing power if consumers continue trading down or retailers push harder on supplier terms.

What does recent Unilever share performance say about sentiment?

Unilever shares closed September 15 at £46.42, down 1.18% during the session and roughly 16% below their 52-week high, although that trading session preceded the Competition and Markets Authority’s formal September 16 launch and therefore should not be described as a reaction to the investigation.

Investor sentiment toward the food transaction has been mixed since its announcement. Reuters reported in March that both Unilever and McCormick shares initially fell after the deal was unveiled, reflecting questions about valuation, execution and whether the structure creates enough incremental value for shareholders.

The regulatory review now adds another measurable milestone to that debate. The core question is no longer whether Unilever intends to simplify its portfolio, because management has clearly committed to that direction. The issue is whether the company can execute a complex transaction on acceptable regulatory terms while preserving the financial benefits expected from the separation.